Is AbbVie a good investment?
Key Points
- AbbVie's dividend growth heavily rewards patient shareholders.
- Revenue is unlikely to grow quickly enough to make new investors rich overnight.
- There's more to becoming wealthy than buying millionaire-maker stocks and hoping for the best.
Is AbbVie a good dividend stock to buy right now?
With a dividend program already on solid footing and new drugs driving growth, AbbVie looks like a great dividend stock to buy right now. When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
Is AbbVie a bad news buy?
The U.S. Food and Drug Administration (FDA) has placed additional warnings on the labels for JAK inhibitors marketed by AbbVie (NYSE ... or could more bad news be on the way?
Should you buy abbv stock?
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks ... Investors should also note AbbVie's current ...
See more
Is it a good time to buy AbbVie stock?
The AbbVie stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
What is the target price for AbbVie?
Stock Price TargetHigh$200.00Low$135.00Average$163.75Current Price$147.75
Does AbbVie pay monthly dividends?
(NYSE: ABBV) today declared a quarterly cash dividend of $1.41 per share. The cash dividend is payable May 16, 2022 to stockholders of record at the close of business on April 15, 2022. Since the company's inception in 2013, AbbVie has increased its dividend by more than 250 percent.
Is AbbVie a qualified dividend?
The AbbVie dividend (as an Abbott Labs spin off) has increased for 50 consecutive years; qualifying the company as a Dividend King.
Is AbbVie a Buy Sell or Hold?
Valuation metrics show that AbbVie Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of ABBV, demonstrate its potential to outperform the market.
Did AbbVie stock split?
According to our AbbVie stock split history records, AbbVie has had 0 splits.
Will AbbVie raise dividends in 2021?
(NYSE: ABBV) today declared a quarterly cash dividend of $1.30 per share. The cash dividend is payable August 16, 2021 to stockholders of record at the close of business on July 15, 2021. Since the company's inception in 2013, AbbVie has increased its dividend by 225 percent.
How many times a year does ABBV pay dividends?
AbbVie pays dividends every 3 months or 4 times per year. Each quarterly dividend payment is one-fourth of the company's annual dividend rate.
Which stock has the highest dividend?
9 highest dividend-paying stocks in the S&P 500:AT&T Inc. (T)Williams Cos. Inc. (WMB)Devon Energy Corp. (DVN)Oneok Inc. (OKE)Simon Property Group Inc. (SPG)Kinder Morgan Inc. (KMI)Vornado Realty Trust (VNO)Altria Group Inc. (MO)More items...•
What is the next ex dividend date for AbbVie 2021?
ABBV Dividend HistoryEx/EFF DATETYPEPAYMENT DATE01/13/2022CASH02/15/202210/14/2021CASH11/15/202107/14/2021CASH08/16/202104/14/2021CASH05/14/202133 more rows
What stocks pay dividends monthly?
No business development companies (BDC), which are a risky segment that often pays monthly dividends....Realty Income (O) ... SL Green (SLG) ... STAG Industrial (STAG) ... AGNC Investment (AGNC) ... Apple Hospitality REIT (APLE) ... EPR Properties (EPR) ... Agree Realty (ADC)
Does AbbVie have a drip?
AbbVie offers a solid DRIP plan for DRIP investors. All cash purchase and dividend reinvestment fees are paid by the company.
Should I buy or sell AbbVie stock right now?
16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last year. There are currently 1 sell rat...
What is AbbVie's stock price forecast for 2022?
16 Wall Street analysts have issued 12 month price targets for AbbVie's stock. Their ABBV stock forecasts range from $135.00 to $200.00. On average...
How has AbbVie's stock price performed in 2022?
AbbVie's stock was trading at $135.40 at the beginning of the year. Since then, ABBV stock has increased by 5.8% and is now trading at $143.20. Vi...
When is AbbVie's next earnings date?
AbbVie is scheduled to release its next quarterly earnings announcement on Friday, July 29th 2022. View our earnings forecast for AbbVie .
How were AbbVie's earnings last quarter?
AbbVie Inc. (NYSE:ABBV) posted its quarterly earnings results on Friday, April, 29th. The company reported $3.16 earnings per share (EPS) for the q...
How often does AbbVie pay dividends? What is the dividend yield for AbbVie?
AbbVie announced a quarterly dividend on Thursday, February 17th. Shareholders of record on Friday, April 15th will be given a dividend of $1.41 pe...
Is AbbVie a good dividend stock?
AbbVie(NYSE:ABBV) pays an annual dividend of $5.64 per share and currently has a dividend yield of 3.94%. AbbVie has been increasing its dividend f...
What guidance has AbbVie issued on next quarter's earnings?
AbbVie updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share (EPS) guidance of $13.92-$14.12 for the p...
Who are AbbVie's key executives?
AbbVie's management team includes the following people: Mr. Richard A. Gonzalez , Chairman & CEO (Age 68, Pay $7.42M) ( LinkedIn Profile ) Mr. R...
How much does Abbvie make?
Is Abbvie a dividend payer?
AbbVie has a market capitalization of $208.04 billion and generates $45.80 billion in revenue each year. The company earns $4.62 billion in net income (profit) each year or $10.56 on an earnings per share basis.